Credent Connect N Care IPO
Upcoming SMEAlready have an account? Apply now
Credent Connect N Care IPO details
Schedule of Credent Connect N Care
| Issue open date | 13 Aug 2026 |
| Issue close date | 17 Aug 2026 |
| UPI mandate deadline | 17 Aug 2026 (5 PM) |
| Allotment finalization | 18 Aug 2026 |
| Refund initiation | 19 Aug 2026 |
| Share credit | 19 Aug 2026 |
| Listing date | 20 Aug 2026 |
| Mandate end date | 01 Sep 2026 |
| Lock-in end date for anchor investors (50%) | 16 Sep 2026 |
| Lock-in end date for anchor investors (remaining) | 15 Nov 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Credent Connect N Care
Credent Connect N Care Limited is a healthcare services provider that delivers integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. The company’s core business involves providing comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, and other healthcare enterprises. Its main offerings include temperature-controlled and time-sensitive transportation of diagnostic samples, home sample collection by trained phlebotomists, and the deployment of skilled laboratory technicians and paramedical staff at client locations. The company also manages large-scale corporate wellness programs and health camps under its “C3 Wellness” brand and operates “C3 Post,” a smart courier aggregation platform for bulk shipping, which includes cold-chain logistics. Revenue is generated directly from providing these varied logistics, operational, and healthcare support services to its business-to-business clients.
Financials of Credent Connect N Care
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 93.90 |
| Fresh Issue – Proceeds go to the company | 93.90 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Finance subsidiary’s working capital |
26.8 (28.54%) |
| Capex for subsidiary’s machinery | 3 (3.19%) |
| Part-finance working capital requirements | 37 (39.40%) |
| Repay or pre-pay certain borrowings | 6 (6.39%) |
| General corporate purposes | 21.1 (22.47%) |
Strengths
- Operates a comprehensive healthcare ecosystem and logistics platform.
- Has established relationships with over 2,500 diagnostic laboratories across India.
- Leverages the extensive industry experience of its promoters and directors.
- Maintains a widespread domestic reach with operations across multiple states.
- Expanded service capabilities through the strategic acquisition of three wholly-owned subsidiaries.
Risks
- High revenue concentration, with the top 10 customers contributing over 80% of revenue.
- Significant dependence on the financial health and testing volumes of diagnostic and healthcare companies.
- Exposed to operational risks of sample loss, damage, or contamination during transportation.
- Business is working capital intensive, with a large portion of assets held as trade receivables.
- Operations are highly dependent on a large, geographically dispersed workforce of over 6,300 employees.